Pages that link to "Q44112412"

The following pages link to Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats (Q44112412):

Displaying 33 items.

• Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardia (Q28569783) (← links)
• Peroxisome proliferator-activated receptor gamma overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells (Q28573588) (← links)
• PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4 (Q28574163) (← links)
• Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway (Q28580167) (← links)
• Effect of lifestyle intervention plus rosiglitazone or placebo therapy on left ventricular mass assessed with cardiovascular magnetic resonance in the metabolic syndrome (Q30472847) (← links)
• Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular performance, cardiac structure, and function (Q34123775) (← links)
• Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism (Q34150535) (← links)
• Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro (Q34576530) (← links)
• Suppression of cardiac myocyte hypertrophy by conjugated linoleic acid: role of peroxisome proliferator-activated receptors alpha and gamma (Q34751805) (← links)
• Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure (Q35111553) (← links)
• Type 2 diabetes, cardiovascular risk, and the link to insulin resistance (Q35557355) (← links)
• Cardiovascular effects of the thiazolidinediones. (Q36268105) (← links)
• PPAR-gamma in the Cardiovascular System (Q36426786) (← links)
• Roles of PPARs on regulating myocardial energy and lipid homeostasis (Q36759083) (← links)
• Peroxisome proliferator-activated receptors and inflammation: take it to heart (Q36970664) (← links)
• PPAR-gamma expression in animals subjected to volume overload and chronic Urotensin II administration (Q37422701) (← links)
• Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization. (Q37474984) (← links)
• PPARgamma as a potential therapeutic target in pulmonary hypertension (Q37689190) (← links)
• Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection. (Q38640842) (← links)
• Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes (Q39598383) (← links)
• Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function (Q42834790) (← links)
• Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan (Q42859670) (← links)
• Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy (Q43036719) (← links)
• Activation of PPARgamma by pioglitazone does not attenuate left ventricular hypertrophy following aortic banding in rats (Q43182357) (← links)
• The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats (Q43210917) (← links)
• Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats (Q45220355) (← links)
• Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats. (Q46906334) (← links)
• Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance. (Q49908591) (← links)
• Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats (Q50691502) (← links)
• Apigenin Attenuates β-Receptor-Stimulated Myocardial Injury Via Safeguarding Cardiac Functions and Escalation of Antioxidant Defence System. (Q53420523) (← links)
• Activation of peroxisome proliferator-activated receptor-alpha and -gamma in auricular tissue from heart failure patients. (Q54640549) (← links)
• Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes (Q80648047) (← links)
• Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway (Q91235381) (← links)